John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive


Diagnostic, causes et pronostic de l’insuffisance rénale aiguë au cours de la cirrhose Volume 26, numéro 2, Février 2019

  • [1] Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol 2015 ; 62 : 968-974.
  • [2] Durand F., Olson J.C., Nadim M.K. Renal dysfunction and cirrhosis. Curr Opin Crit Care. 2017;23:457-462.
  • [3] Laffi G., La Villa G., Pinzani M. Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol. 1997;17:530-548.
  • [4] Schrier R.W., Arroyo V., Bernardi M. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1998;8:1151-1157.
  • [5] Krag A., Bendtsen F., Henriksen J.H. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59:105-110.
  • [6] Ruiz-Del-Arbol L., Monescillo A., Arocena C. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439-447.
  • [7] Wong F., Villamil A., Angeli P. The mid-term outcome in patients with decompensated cirrhosis and diastolic dysfunction. Hepatology. 2012;56:946A.
  • [8] Prowle J.R., Bellomo R. Sepsis-associated acute kidney injury : macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35:64-74.
  • [9] Thabut D., Massard J., Gangloff A. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46:1872-1882.
  • [10] Shah N., Dhar D., El Zahraa Mohammed F. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol. 2012;56:1047-1053.
  • [11] Shah N., Mohamed F.E., Jover-Cobos M. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int. 2013;33:398-409.
  • [12] Mandal A.K., Lansing M., Fahmy A. Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study. Am J Kidney Dis. 1982;2:363-374.
  • [13] Ginès P., Schrier R.W. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279-1290.
  • [14] Koppel M.H., Coburn J.W., Mims M.M. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med. 1969;280:1367-1371.
  • [15] Arroyo V., Gines P., Gerbes A.L. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23:164-176.
  • [16] Salerno F., Gerbes A., Ginès P. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310-1318.
  • [17] European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018 ; 69 : 406-460.
  • [18] Sherman D.S., Fish D.N., Teitelbaum I. Assessing renal function in cirrhotic patients: Problems and pitfalls. Am J Kidney Dis. 2003;41:269-278.
  • [19] Moreau R, Jalan R, Gines P, et al. ; CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013 ; 144 (07) : 1426-1437, 1437.e1-1437.
  • [20] Nadim M.K., Durand F., Kellum J.A. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol. 2016;64:717-735.
  • [21] Amathieu R., Al-Khafaji A., Sileanu F.E. Significance of Oliguria in Critically Ill Patients with Chronic Liver Disease. Hepatology. 2017;66:1592-1600.
  • [22] Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008;46:2064-2077.
  • [23] Belcher J.M., Parikh C.R., Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: Perils and promise. Clin Gastroenterol Hepatol. 2013;11:1550-1558.
  • [24] Wong F., Jepsen P., Watson H. Unprecipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites. Liver Int. 2018;38:1785-1792.
  • [25] Ferenbach D.A., Bonventre J.D. Mechanisms of maladaptive repair after insuffisance rénale aiguë leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015;11:264-276.
  • [26] Chou Y.H., Chu T.S., Lin S.L. Role of renin-angiotensin in acute kidney injury-chronic kidney disease transition. Nephrology. 2018;23:121-125.
  • [27] Klein J., Miravete M., Buffin-Meyer B. Tubulo-interstitial fibrosis: An emerging major health problem. Med Sci (Paris). 2011;27:55-61.
  • [28] Piano S., Rosi S., Maresio G. Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol. 2013;59:482-489.
  • [29] Fagundes C., Barreto R., Guevara M. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol. 2013;59:474-481.
  • [30] Huelin P, Piano S, Sola E, et al. Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure. Clin Gastroenterol Hepatol 2017 ; 15 : 438-445.
  • [31] Martín-Llahí M., Guevara M., Torre A., Fagundes C. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterolology. 2011;140:488-496.
  • [32] Schrier R.W. Fluid administration in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2010;5:733-739.
  • [33] Francoz C, Nadim MK, Durand F. Kidney Biomarkers in Cirrhosis. J Hepatol 2016 ; 65 : 809-824.
  • [34] Marx D., Metzger J., Pejchinovski M. Proteomics and Metabolomics for insuffisance rénale aiguë. Diagnosis. Semin Nephrol. 2018;38:63-87.